Clinical, Pharmacodynamic, and Pharmacokinetic Evaluation of BNC105P: A Phase I Trial of a Novel Vascular Disrupting Agent and Inhibitor of Cancer Cell Proliferation

2011 ◽  
Vol 17 (15) ◽  
pp. 5152-5160 ◽  
Author(s):  
Danny Rischin ◽  
David C. Bibby ◽  
Geoff Chong ◽  
Gabriel Kremmidiotis ◽  
Annabell F. Leske ◽  
...  
2010 ◽  
Vol 103 (5) ◽  
pp. 597-606 ◽  
Author(s):  
J D Lickliter ◽  
A B Francesconi ◽  
G Smith ◽  
M Burge ◽  
A Coulthard ◽  
...  

2012 ◽  
Vol 18 (5) ◽  
pp. 1415-1425 ◽  
Author(s):  
Dan M. Patterson ◽  
Martin Zweifel ◽  
Mark R. Middleton ◽  
Patricia M. Price ◽  
Lisa K. Folkes ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A615-A615
Author(s):  
S KUWADA ◽  
C SCAIFE ◽  
J KUANG ◽  
R DAYNES

Planta Medica ◽  
2012 ◽  
Vol 78 (11) ◽  
Author(s):  
S Sun ◽  
M Zhang ◽  
M Li ◽  
F Guan ◽  
F Wu ◽  
...  

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1957-P
Author(s):  
TAKAKO KAWANAMI ◽  
TAKASHI NOMIYAMA ◽  
YURIKO HAMAGUCHI ◽  
TOMOKO TANAKA ◽  
TOSHIHIKO YANASE

Sign in / Sign up

Export Citation Format

Share Document